| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |